Pancreatic Cancer Treatment Updates from ASCO 2025: Key Insights for Oncologists ASCO 3 Mins Read Introduction to Pancreatic Cancer Treatment at ASCO 2025 At the ASCO 2025 Annual Meeting, Dr. Brian Wolpin presented groundbreaking updates…
Advanced Pancreatic Cancer Comparing First-Line Treatments: A Pooled Analysis of Phase 3 Trials Pancreatic 3 Mins Read Dr. Monica Niger, from Fondazione IRCCS Istituto Nazionale Tumori, provided a summary of the NALIRIFOX vs FOLFIRINOX vs gemcitabine plus…
